Bright Minds

This article by Sarah Abelsohn was originally published on Psychedelic Spotlight and appears here with permission. In today’s episode of the Psychedelic Spotlight podcast, the Psychedelic Investor, James Hallifax interviews Ian McDonald, CEO and Director of Bright Minds Biosciences (NASDAQ:...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Bright Minds Biosciences (OTC: BMBIF), a Canadian-based biotechnology company, is developing the next-generation serotonergic drugs...

Boston Suburbs Look To Decriminalize Natural Psychedelics Two Boston suburbs are the latest U.S. jurisdictions to eliminate penalties on the possession and cultivation of entheogenic plants and fungi. That includes psilocybin mushrooms, ayahuasca, the peyote cacti and the iboga...